Login/Sign Up
MRP ₹80
(Inclusive of all Taxes)
₹12.0 Cashback (15%)
Provide Delivery Location
Online payment accepted
Whats That
About Hetriva 18 Transdermal Patch
Hetriva 18 Transdermal Patch belongs to a group of medicines called 'anti-dementia agents' used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. Alzheimer's disease is a neurological disorder, which causes dementia (memory loss), and slowly destroys the ability to think, learn, communicate, and handle daily activities. Parkinson's disease is a central nervous system disorder that affects movement leading to shaking, stiffness, and difficulty with walking, balance, and coordination.
Hetriva 18 Transdermal Patch contains 'Rivastigmine' that belongs to the class of 'Acetylcholinesterase Inhibitors'. Rivastigmine increases the cholinergic effects allowing the nerve cells to communicate. It restores the balance of neurotransmitters and improves mental function, such as memory and thinking. Neurotransmitters are chemical messengers that transmit the message from one nerve cell to another nerve cell, muscle cell, or gland cell.
Use Hetriva 18 Transdermal Patch as prescribed by your doctor. Your doctor will decide the dose and duration based on the severity of your disease. Common side effects of Hetriva 18 Transdermal Patch include nausea, vomiting, diarrhoea, stomach upset, stomach pain, headache, anxiety, depression/low mood, trouble sleeping, dizziness, drowsiness, shakiness (tremor), weakness/tiredness, weight loss/loss of appetite, and skin irritation at the application site. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Let your doctor know if you are taking any prescription and non-prescription medications, including other vitamins, before using Hetriva 18 Transdermal Patch. Please tell your doctor if you are allergic to any medicines. Inform your doctor beforehand if you have a history of liver or kidney diseases, breathing problems (asthma, chronic obstructive pulmonary disease (COPD)), stomach/intestinal problems (ulcers, bleeding), heart diseases (sick sinus syndrome and conduction disorders), fainting, fits, urination problems, and enlarged prostate. It is essential to let your doctor know if you are pregnant, planning to conceive or a breastfeeding mother. Avoid consuming alcohol and driving/operating machinery while being treated with Hetriva 18 Transdermal Patch as it can make you dizzy or drowsy.
Uses of Hetriva 18 Transdermal Patch
Directions for Use
Medicinal Benefits
Hetriva 18 Transdermal Patch treats mild to moderate dementia caused by Alzheimer's and Parkinson's diseases. It contains 'Rivastigmine', an acetylcholinesterase inhibitor. Rivastigmine increases acetylcholine (a brain chemical) levels in the central nervous system involved in transmitting nerve signals that play an essential role in memory. Hetriva 18 Transdermal Patch is not a cure for Alzheimer's and Parkinson's diseases but improves memory, thinking awareness, and the ability to perform daily functions.
Storage
Drug Warnings
Let your doctor know if you use any other medicines or supplements before using Hetriva 18 Transdermal Patch. Brief your medical history if you have any liver or kidney diseases, breathing problems (asthma, chronic obstructive pulmonary disease (COPD)), stomach/intestinal problems (ulcers, bleeding), heart diseases (sick sinus syndrome and other conduction disorders), fainting, fits, urination problems, and enlarged prostate. Do not apply another patch when you are already using a patch since it can lead to overdosing. Please consult your doctor know if you are pregnant, planning to conceive or a breastfeeding mother. Avoid consuming alcohol while being treated with Hetriva 18 Transdermal Patch as it might lead to increased side effects. Do not drive or operate machinery as this medicine may cause dizziness and sleepiness. Hetriva 18 Transdermal Patch is not recommended for children below 18 years as safety and effectiveness have not been established.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Side Effects of Hetriva 18 Transdermal Patch
Habit Forming
Therapeutic Class
We provide you with authentic, trustworthy and relevant information
Drug-Diseases Interactions
Login/Sign Up
Hetriva 18 Transdermal Patch contains 'Rivastigmine', an acetylcholinesterase inhibitor. It treats dementia in Alzheimer's and Parkinson's diseases by increasing acetylcholine levels in the central nervous system and enhancing the neurotransmission process. Thus, Hetriva 18 Transdermal Patch improves memory, thinking, and awareness.
Hetriva 18 Transdermal Patch should be used with caution in the medical history of liver or kidney diseases, breathing problems (asthma, chronic obstructive pulmonary disease (COPD)), stomach/intestinal problems (ulcers, bleeding), heart diseases (sick sinus syndrome and other conduction disorders), fainting, fits, urination problems, and enlarged prostate. Please let your doctor know if you have any other medical problems before starting Hetriva 18 Transdermal Patch.
The transdermal patch is to be evenly applied on the skin without hair. It is advised to put the transdermal patch on clean, dry, and healthy skin on the upper or lower back. You can also apply it to the upper arm or chest. The patch should not be put on damaged and broken skin. Please do not apply a new patch when you are already using one patch since it can lead to overdosing. Do not apply creams, oils, lotions, and powder on the site of the application. Sometimes, a patch may contain metal. Hence, it is advised to take off the patch while undergoing an MRI scan.
After using the patch, fold it into half with the adhesive surfaces pressed together inwards, and discard it safely.
Store Hetriva 18 Transdermal Patch in a dry place at room temperature ranging from 20°C to 25°C. Do not store in the washroom. Do not open the sealed pouch/sachet until the patch is ready to use.
Drug-Drug Interactions Checker List
Special Advise
Disease/Condition Glossary
Alzheimer's disease: The disease is named after Dr Alois Alzheimer, who was the first to discover the disease. Alzheimer's disease is a neurological disorder that causes dementia (memory loss), and slowly destroys the ability to think, learn, communicate, and eventually, the ability to handle daily activities. It is the most common cause of dementia (memory loss) in adults. Dementia is the loss of cognitive functioning, such as remembering, thinking, and reasoning. The causes of this disease are abnormal functioning of brain cells which causes a disturbance in communication between them. The risk factors are age, family history and genetics of a person. Alzheimer's disease symptoms include memory loss, trouble with familiar tasks, difficulties with problem-solving, trouble with writing or talking, disorientation, problems with reasoning or judgment, and mood and personality changes. In most people, the symptoms of Alzheimer's appear in their mid-60s.
Parkinson's disease: It is a central nervous system disorder that affects movement leading to shaking, stiffness, and difficulty with walking, balance, and coordination. This disease affects the nerve cells in the brain that produce dopamine (neurotransmitter). Parkinson's disease symptoms include dementia, muscle rigidity, tremors, and changes in speech and gait (pattern of limb movement). This disease generally occurs in people aged 60 years and over. Risk factors of this disease include genetics, environmental triggers, and certain toxins.
Have a query?
Buy best C.n.s Drugs products by
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Alkem Laboratories Ltd
Abbott India Ltd
Cipla Ltd
Alteus Biogenics Pvt Ltd
Micro Labs Ltd
Lupin Ltd
Ipca Laboratories Ltd
D D Pharmaceuticals Pvt Ltd
Icon Life Sciences
Mankind Pharma Pvt Ltd
Tripada Healthcare Pvt Ltd
Arinna Lifesciences Ltd
Linux Laboratories Pvt Ltd
East West Pharma India Pvt Ltd
La Renon Healthcare Pvt Ltd
Talent India Pvt Ltd
Tas Med India Pvt Ltd
Zydus Healthcare Ltd
Cnx Health Care Pvt Ltd
Eris Life Sciences Ltd
Leeford Healthcare Ltd
Emcure Pharmaceuticals Ltd
Macleods Pharmaceuticals Ltd
Sigmund Promedica
Aristo Pharmaceuticals Pvt Ltd
Dr Reddy's Laboratories Ltd
Troikaa Pharmaceuticals Ltd
Consern Pharma Ltd
Zydus Cadila
Shine Pharmaceuticals Ltd
Wockhardt Ltd
Ardent Life Sciences Pvt Ltd
Crescent Formulations Pvt Ltd
Theo Pharma Pvt Ltd
Reliance Formulation Pvt Ltd
Ikon Pharmaceuticals Pvt Ltd
Propel Healthcare
Neon Laboratories Ltd
Jagsam Pharma
Msn Laboratories Pvt Ltd
Morepen Laboratories Ltd
Pulse Pharmaceuticals
Sanofi India Ltd
Med Manor Organics Pvt Ltd
Hetero Healthcare Pvt Ltd
Novartis India Ltd
Crescent Therapeutics Ltd
Elder Pharmaceuticals Ltd
Solvate Laboratories Pvt Ltd
Akumentis Healthcare Ltd
Mova Pharmaceutical Pvt Ltd
Psyco Remedies Ltd
Tripada Lifecare Pvt Ltd
Ajanta Pharma Ltd
Cyrus Remedies Pvt Ltd
Medishri Healthcare Pvt Ltd
Cadila Healthcare Ltd
Glenmark Pharmaceuticals Ltd
Matteo Health Care Pvt Ltd
Hbc Life Sciences Pvt Ltd
Lyf Healthcare
Matias Healthcare Pvt Ltd
Mesmer Pharmaceuticals
Alembic Pharmaceuticals Ltd
Capital Pharma
Crescent Pharmaceuticals
Medopharm Pvt Ltd
Alniche Life Sciences Pvt Ltd
Kivi Labs Ltd
Talin Remedies Pvt Ltd
USV Pvt Ltd
Quince Lifesciences Pvt Ltd
Solis Pharmaceuticals
Infivis Life Care
Zuventus Healthcare Ltd
Cadila Pharmaceuticals Ltd
Pfizer Ltd
Wallace Pharmaceuticals Pvt Ltd
A N Pharmacia Laboratories Pvt Ltd
Blue Cross Laboratories Pvt Ltd
Jenburkt Pharmaceuticals Ltd
Lia Life Sciences Pvt Ltd
Mano Pharma
Medley Pharmaceuticals Ltd
Primus Remedies Pvt Ltd
FDC Ltd
Maneesh Pharmaceuticals Ltd
Apex Laboratories Pvt Ltd
Gagnant Healthcare Pvt Ltd
Ozone Pharmaceuticals Ltd
RPG Life Sciences Ltd
Strides Shasun Ltd
Unichem International
GlaxoSmithKline Pharmaceuticals Ltd
Kuresys Labs Pvt Ltd
LA Pharma
Trion Pharma India Llp
Alcohol
Unsafe
It is advised to avoid alcohol consumption while using Hetriva 18 Transdermal Patch. Alcohol intake, along with Hetriva 18 Transdermal Patch, may cause increased dizziness and drowsiness. Please consult your doctor for more information.
Pregnancy
Caution
Hetriva 18 Transdermal Patch should be used during pregnancy only if the benefit outweighs the risk. Please consult your doctor before using Hetriva 18 Transdermal Patch if you are pregnant or planning to conceive.
Breast Feeding
Caution
It is not known if Hetriva 18 Transdermal Patch is excreted into breast milk. Please consult your doctor before using Hetriva 18 Transdermal Patch if you are breastfeeding.
Driving
Caution
Hetriva 18 Transdermal Patch may make you feel dizzy or drowsy. Do not drive if you experience any symptoms that affect your ability to drive or operate machinery.
Liver
Caution
Please consult your doctor before using Hetriva 18 Transdermal Patch if you have liver problems.
Kidney
Caution
Please consult your doctor before using Hetriva 18 Transdermal Patch if you have kidney impairment.
Children
Caution
It is not known if Hetriva 18 Transdermal Patch is safe to use in patients below 18 years of age. Please seek medical advice for more information.